Articles

Poll

Podcasts

Slideshows

Videos

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.

Intensive Blood Pressure Regimen Lowers CVD Risk in People with T2D 

In this episode, hosts explore the most recent updates surrounding GLP-1 receptor agonists, including GLP-1 shortages and long-term data on tirzepatide.

Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data

In this episode, hosts discuss the latest developments in GLP-1 receptor agonists, with a particular focus on semaglutide.

Diabetes Dialogue: Latest Updates on Semaglutide

In this episode, hosts spotlight updates on Abbott’s Libre 3, Tidepool integration, and Omnipod 5 iOS app, expanding flexibility in diabetes management.

Diabetes Dialogue: Diabetes Tech Updates in October 2024 

Brandon Arbiter joins the podcast to discuss the latest updates from Tidepool. 

Diabetes Dialogue: Tidepool Updates, with Brandon Arbiter

The 11 to 3 vote against the benefit-risk profile of sotagliflozin comes with less than 2 months to go until the December 20, 2024 PDUFA date.

FDA Committee Casts Negative Vote on Sotagliflozin in Type 1 Diabetes

SF-36v2 scores also improved by 12 points with semaglutide compared with 6.5 points with placebo.

Semaglutide Reduces Knee Osteoarthritis Pain in People With Obesity

A decade after bariatric surgery, most teens maintained weight loss and reduced obesity-related conditions such as type 2 diabetes and hypertension.

10-Year Follow-Up Shows Lasting Benefits of Bariatric Surgery for Teens with Severe Obesity

Richard Pratley, MD, discusses how FLOW mortality data informs the use of semaglutide in patients with chronic kidney disease and type 2 diabetes.

Richard Pratley, MD: FLOW Mortality Data and Allocation Strategies for Semaglutide

Novo Nordisk will present more detailed data in 2025 and plans to file for an expanded label for Rybelsus for this population. 

Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD  

Type 2 Diabetes

Type 1 Diabetes

Polycystic Ovary Syndrome

Hormonal Disorders

Thyroid Disorders

The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Endocrinology